title: Should screening programs for carbapenemase-producing strains be implemented in ICU patients?
authors.affiliation: Laboratorio de Referencia e Investigación en Resistencia a Antibióticos e Infecciones Relacionadas con la Asistencia Sanitaria, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, España. Electronic address: jesus.oteo@isciii.es.
authors.forename: Jesús
authors.initials: J
authors.lastname: Oteo
mesh_terms: D001426:Bacterial Proteins / Q000096:biosynthesis*; D003428:Cross Infection / Q000188:drug therapy / Q000517:prevention & control*; D000076862:Diagnostic Screening Programs / Q000458:organization & administration; D024881:Drug Resistance, Bacterial; D004755:Enterobacteriaceae / Q000201:enzymology* / Q000302:isolation & purification; D004756:Enterobacteriaceae Infections / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D007362:Intensive Care Units; D001618:beta-Lactamases / Q000096:biosynthesis*
chemical_list: D001426:Bacterial Proteins; D001618:beta-Lactamases; C063912:carbapenemase